Score
Based on recent headline ratings, 83% of this readership currently trusts the local media, which has an average score of 91% regionally and is currently trending negative.
Media Trust Score83%

FDA clears nano-pulse stimulation tech for treating hyperplasia from Pulse Biosciences

Hayward, California-based Pulse Biosciences said CellFX represents the first commercial product to use NPS technology to treat a variety of …

  • You already voted!
  • Read More